Evidence map›Paper›PMID 33806359›Full record

ArticleInternational journal of molecular sciences2021

Adverse Prognostic Impact of the

Nicole Naumann, Johannes Lübke, Sofie Baumann, Juliana Schwaab, Oliver Hoffmann, Sebastian Kreil, Vito Dangelo, Lukas Reiter, Peter Bugert, Thomas Kristensen and 11 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Detection ofInternational journal of molecular sciences · 2024
    Review
  6. Review
  7. Therapeutic advances of targeting receptor tyrosine kinases in cancer.Signal transduction and targeted therapy · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 4 countries.

Nicole NaumannDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Johannes LübkeDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Sofie BaumannDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Juliana SchwaabDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.ORCID 0000-0001-9208-5264
Oliver HoffmannDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Sebastian KreilDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Vito DangeloDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Lukas ReiterDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Peter BugertInstitute of Transfusion Medicine and Immunology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Thomas KristensenMastocytosis Center, Odense University Hospital, 5000 Odense, Denmark.
Karl SotlarUniversity Hospital Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria.
Verena HaselmannInstitute for Clinical Chemistry, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Sven SchneiderInstitute for Clinical Chemistry, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Georgia MetzgerothDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Christel WeissDepartment of Medical Statistics and Biomathematics, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Henning D PoppDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.ORCID 0000-0003-0090-0204
Alice FabariusDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Wolf-Karsten HofmannDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Nicholas C P CrossSchool of Medicine, University of Southampton, Southampton SO17 1BJ, UK.ORCID 0000-0001-5481-2555
Andreas ReiterDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Mohamad JawharDepartment of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.ORCID 0000-0001-9148-9398
Heidelberg University · DEOdense University Hospital · DKParacelsus Medical University · ATWessex Regional Genetics Laboratory · GB

Funding

José Carreras Leukämie-Stiftung DJCLS 01R/2018 and DJCLS-08R/2020
6 · The paper itself

Abstract

In systemic mastocytosis (SM), qualitative and serial quantitative assessment of the

Indexed as

MutationAdultAgedAged, 80 and overAmino Acid SubstitutionBone MarrowDNAFemaleGene FrequencyHumansMaleMastocytosis, SystemicMiddle AgedPhenotypePrognosisProto-Oncogene Proteins c-kitDNAKIT protein, humanProto-Oncogene Proteins c-kitRNAadvanced SMallele burdenKIT D816Vsurvivalvariant allele frequency

Identifiers

PMID33806359
PMCPMC7961551
OpenAlexW3134399556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.